ENDOLIPID THERAPEUTICS

endolipid-therapeutics-logo

ENDOLIPID THERAPEUTICS is a biotechnology research agency.

#People #Website #More

ENDOLIPID THERAPEUTICS

Website Url:
http://www.endolipid.com

Status:
Active


Current Employees Featured

albert-palomer_image

Albert Palomer
Albert Palomer CEO @ ENDOLIPID THERAPEUTICS
CEO
2021-05-01

Official Site Inspections

http://www.endolipid.com

  • Host name: mail.ideamatic.net
  • IP address: 82.98.132.224
  • Location: Spain
  • Latitude: 40.4172
  • Longitude: -3.684
  • Timezone: Europe/Madrid

Loading ...

More informations about "ENDOLIPID THERAPEUTICS"

EndoLipiD Therapeutics

Endolipid receives a grant from EU Next Generation Funds to develop the NASH peptide. The Team. Albert Palomer, PhD CEO. Senior Executive and Development Consultant / Former CEO ABAC Therapeutics and Head of Med โ€ฆSee details»

ENDOLIPID THERAPEUTICS - Crunchbase Company Profile

ENDOLIPID THERAPEUTICS is located in Barcelona, Catalonia, Spain. Who are ENDOLIPID THERAPEUTICS 's competitors? Alternatives and possible competitors to ENDOLIPID โ€ฆSee details»

Endolipid - Company Profile - Tracxn

Jan 28, 2025 EndoLipiD Therapeutics is a company focused on developing peptide products for NASH and cellulite treatment. They are currently in preclinical stages and have a unique โ€ฆSee details»

ENDOLIPID THERAPEUTICS Overview | SignalHire Company Profile

Organization Website: endolipid.com : ENDOLIPID THERAPEUTICS industries Biotech: Headquarters Location: Passeig de la Vall dโ€™Hebron 119-129, Barcelona , Spain, 08035 ES โ€ฆSee details»

EndoLipiD Therapeutics - PitchBook

EndoLipiD Therapeutics General Information Description. Developer of therapeutic applications designed to reduce ectopic fat. The company's therapy helps to reduce fat, fibrosis and โ€ฆSee details»

Endolipid therapeutics | VHIR - Vall d'Hebron Institut โ€ฆ

Endolipid therapeutics is established in early 2021 with the participation of dr. David Martinez Selva and Dr. Rafael Simó, who will act as scientific director (CSO) and medical advisor on behalf of the VHIR, together with two external โ€ฆSee details»

Endolipid Therapeutics - Drug pipelines, Patents, Clinical trials

Explore Endolipid Therapeutics with its drug pipeline, therapeutic area, technology platform, .See details»

EndoLipiD Therapeutics - Products, Competitors, Financials, โ€ฆ

EndoLipiD Therapeutics specializes in biopharmaceuticals, focusing on the development of peptide-based therapies for metabolic and dermatological conditions. Use the CB Insights โ€ฆSee details»

Endolipid Therapeutics SL Sociedad Unipersonal - Drug pipelines ...

Mar 13, 2025 Explore Endolipid Therapeutics SL Sociedad Unipersonal with its drug pipeline, therapeutic area, technology platform, .See details»

ENDOLIPID THERAPEUTICS - Tech Stack, Apps, Patents

Organization. ENDOLIPID THERAPEUTICS . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. โ€ฆSee details»

Endolipid Therapeutics, the spin-off of Vall dโ€™Hebron and

Jun 16, 2021 Endolipid Therapeutics S.L. Endolipid Therapeutics S.L. is staffed, at the top tier, by Dr David Martínez Selva and Dr Rafael Simó, who will be the Scientific Director and Medical Advisor respectively. The company also has โ€ฆSee details»

Genesis Biomed | Endolipid Therapeutics, the spin-off of Vall โ€ฆ

With the aim of developing a therapy to reduce visceral fat, Endolipid Therapeutics S.L., a new spin-off from Vall dโ€™Hebron, has emerged based on a research project from the Diabetes and โ€ฆSee details»

- EndoLipiD Therapeutics

Galeta Durada Descripció; cookielawinfo-checkbox-analytics: 11 months: This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in โ€ฆSee details»

Endolipid Therapeutics, the spin-off of Vall dโ€™Hebron and GENESIS ...

Endolipid Therapeutics has developed a new approach to reducing visceral fat with therapeutic applications to treat, for example, fatty liver, and applications will be developed to reduce โ€ฆSee details»

Endolipid Therapeutics - Capital Cell

Endolipid Therapeutics ha alcanzado con éxito el hito establecido en la ronda anterior: cuentan con un candidato preclínico (EDL6D) para abordar la enfermedad del hígado graso no โ€ฆSee details»

Endolipid Therapeutics 2022 - Capital Cell

Así, Endolipid puede ofrecer a sus inversores un primer โ€œpequeñoโ€ exit (estimación x5) a un plazo de 2-3 años, y uno mucho mayor (estimación x26) a un plazo de 4-5 años. Esta doble โ€ฆSee details»

EndoDiabLipid.com | Home

Date: 9th December 2024 - 10th December 2024 Venue: DoubleTree by Hilton, Manchester Airport (International Hybrid Event) Organisers: Professor Handrean Soran & Dr Maryam โ€ฆSee details»

Endolipid Derma SL: consulte teléfono, CIF y dirección - eInforma

Si está interesado en conocer más datos de la empresa ENDOLIPID DERMA S.L. puede acceder inmediatamente a este Informe ampliado de ENDOLIPID DERMA S.L. y consultar los โ€ฆSee details»

Endolipid Therapeutics, the spin-off of Vall dโ€™Hebron and

The accumulation of ectopic fat, especially in the abdomen (visceral fat), is an independent cardiovascular risk factor and is also associated with non-alcoholic fatty liver, a condition that โ€ฆSee details»

Targeted Lipidomics: Endocannabinoids and other Endolipid โ€ฆ

Targeted Lipidomics: Endocannabinoids and other Endolipid Modulators Targeted Lipidomics Workshop: Lipid Signaling Molecules, Endogenous Lipid Modulators (Endolipids) and Drugs of โ€ฆSee details»